Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bar-Ad

Showing results (81-90 of 114) with videos related to

Pageof 12
Sort By:
Journal of Neurological Surgery. Part B, Skull Base|December 31, 2020
Loss of <i>SMARCB1</i> Expression Confers Poor Prognosis to Sinonasal Undifferentiated CarcinomaChandala Chitguppi, Mindy R Rabinowitz, Jennifer Johnson, et al.
Biomed Research International|January 19, 2016
Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-AnalysisCory D Bovenzi, James Hamilton, Patrick Tassone, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 4, 2019
Phase I trial of alisertib with concurrent fractionated stereotactic re-irradiation for recurrent high grade gliomasAndrew Song, David W Andrews, Maria Werner-Wasik, et al.
Advances in Radiation Oncology|July 12, 2024
Association Between Time From Surgery to Radiation Therapy and Multimodality Treatment Outcomes in HPV+ Head and Neck Cancer: A Multi-Institutional Cohort ExperienceMuneeb Niazi, Ryan Miller, Ryann Kolb, et al.
International Journal of Radiation Oncology, Biology, Physics|September 26, 2023
A Phase 1 Study of the DNA-PK Inhibitor Peposertib in Combination With Radiation Therapy With or Without Cisplatin in Patients With Advanced Head and Neck TumorsMichael Samuels, Johan Falkenius, Voichita Bar-Ad, et al.
International Journal of Radiation Oncology, Biology, Physics|June 19, 2012
Assessing the value of an optional radiation oncology clinical rotation during the core clerkships in medical schoolNicholas G Zaorsky, Theresa M Malatesta, Robert B Den, et al.
Journal of Neuro-Oncology|May 31, 2015
Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always betterJoshua D Palmer, Joshua Siglin, Kosj Yamoah, et al.
International Journal of Radiation Oncology, Biology, Physics|August 2, 2025
Phase 2 Study of Low-Dose Paclitaxel and Cisplatin in Combination With Split-Course Concomitant Twice-Daily Reirradiation in Recurrent Squamous Cell Carcinoma of the Head and Neck: Long-term Follow-up of NRG Oncology Radiation Therapy Oncology Group Protocol 9911Corey J Langer, Jonathan Harris, Eric M Horwitz, et al.
Journal of Neuro-Oncology|April 15, 2014
Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trialWenyin Shi, Yaacov Richard Lawrence, Hak Choy, et al.
International Journal of Radiation Oncology, Biology, Physics|June 20, 2022
Two-Year Tumor Outcomes of a Phase 2B, Randomized, Double-Blind Trial of Avasopasem Manganese (GC4419) Versus Placebo to Reduce Severe Oral Mucositis Owing to Concurrent Radiation Therapy and Cisplatin for Head and Neck CancerCarryn M Anderson, Christopher M Lee, Deborah Saunders, et al.
Pageof 12

Showing results (81-90 of 114) with videos related to

Sort By:
Pageof 12
Journal of Neurological Surgery. Part B, Skull Base|December 31, 2020
Loss of <i>SMARCB1</i> Expression Confers Poor Prognosis to Sinonasal Undifferentiated CarcinomaChandala Chitguppi, Mindy R Rabinowitz, Jennifer Johnson, et al.
Biomed Research International|January 19, 2016
Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-AnalysisCory D Bovenzi, James Hamilton, Patrick Tassone, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 4, 2019
Phase I trial of alisertib with concurrent fractionated stereotactic re-irradiation for recurrent high grade gliomasAndrew Song, David W Andrews, Maria Werner-Wasik, et al.
Advances in Radiation Oncology|July 12, 2024
Association Between Time From Surgery to Radiation Therapy and Multimodality Treatment Outcomes in HPV+ Head and Neck Cancer: A Multi-Institutional Cohort ExperienceMuneeb Niazi, Ryan Miller, Ryann Kolb, et al.
International Journal of Radiation Oncology, Biology, Physics|September 26, 2023
A Phase 1 Study of the DNA-PK Inhibitor Peposertib in Combination With Radiation Therapy With or Without Cisplatin in Patients With Advanced Head and Neck TumorsMichael Samuels, Johan Falkenius, Voichita Bar-Ad, et al.
International Journal of Radiation Oncology, Biology, Physics|June 19, 2012
Assessing the value of an optional radiation oncology clinical rotation during the core clerkships in medical schoolNicholas G Zaorsky, Theresa M Malatesta, Robert B Den, et al.
Journal of Neuro-Oncology|May 31, 2015
Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always betterJoshua D Palmer, Joshua Siglin, Kosj Yamoah, et al.
International Journal of Radiation Oncology, Biology, Physics|August 2, 2025
Phase 2 Study of Low-Dose Paclitaxel and Cisplatin in Combination With Split-Course Concomitant Twice-Daily Reirradiation in Recurrent Squamous Cell Carcinoma of the Head and Neck: Long-term Follow-up of NRG Oncology Radiation Therapy Oncology Group Protocol 9911Corey J Langer, Jonathan Harris, Eric M Horwitz, et al.
Journal of Neuro-Oncology|April 15, 2014
Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trialWenyin Shi, Yaacov Richard Lawrence, Hak Choy, et al.
International Journal of Radiation Oncology, Biology, Physics|June 20, 2022
Two-Year Tumor Outcomes of a Phase 2B, Randomized, Double-Blind Trial of Avasopasem Manganese (GC4419) Versus Placebo to Reduce Severe Oral Mucositis Owing to Concurrent Radiation Therapy and Cisplatin for Head and Neck CancerCarryn M Anderson, Christopher M Lee, Deborah Saunders, et al.
Pageof 12